The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.
Application notesELISA: Use at an assay dependent dilution. IF: Use at an assay dependent dilution. IHC-Fr: Use at an assay dependent dilution. WB: Use at an assay dependent dilution. Predicted molecular weight: 56 kDa. Dilution optimised using Chromogenic detection. Is unsuitable for IHC-P. Not tested in other applications. Optimal dilutions/concentrations should be determined by the end user.
RelevanceHIV1 performs highly complex orchestrated tasks during the assembly, budding, maturation and infection stages of the viral replication cycle. During viral assembly, the proteins form membrane associations and self-associations that ultimately result in budding of an immature virion from the infected cell. Gag precursors also function during viral assembly to selectively bind and package two plus strands of genomic RNA.
Capsid protein p24 probably forms the conical core of the virus that encapsulates the genomic RNA-nucleocapsid complex.
Capsid protein p24 antibody
HIV-1 Gag p24 antibody
Human immunodeficiency virus 1 antibody
Human immunodeficiency virus type 1 p24 antibody
References for Anti-HIV1 p24 antibody  (ab20080)
has not yet been referenced specifically in any publications.
Publishing research using ab20080? Please let us know so that we can cite the reference in this datasheet.
Concentration of lot no. is
Concentration not available for this lot.
Find concentration of your lot:
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"